A new study reveals that glucagon-like peptide-1 receptor agonists (GLP-1), which include weight loss and diabetes meds ...

Expanding access to new, highly effective weight-loss medications could prevent more than 40,000 deaths a year in the United ...

The FDA is weighing a decision that could stop compounding pharmacies from legally making cheaper versions of Mounjaro and ...

Federal regulators shook up the booming weight loss drug marketplace when they announced Mounjaro and Zepbound were no longer ...

The FDA, in a stark reversal, on Friday said it would reconsider its decision to remove Eli Lilly’s tirzepatide from its ...

The FDA updated its database of drugs in shortage to remove tirzepatide, which had sat on that list – along with related ...

There’s a war brewing over blockbuster weight loss medications — and patients are now getting caught in the crossfire.

Not in her tool kit: The weight loss drug du jour. "My doctor chased me for like two years and I was like, 'No, I'm afraid of it. I already have thyroid problems,'" she explained on a May 2024 ...

Jelly Roll's wife Bunnie Xo has revealed she has been 'microdosing' weight-loss medication tirzepatide ... lifted the lid on her experience with the drug on a new episode of her podcast, Dumb ...

The US Food and Drug Administration confirmed Thursday that Eli Lilly (LLY) has increased production of its blockbuster weight-loss drug Zepbound and type 2 diabetes drug Mounjaro, implying the ...

Eli Lilly has finally made enough supply of its popular medicine tirzepatide to meet soaring demand, which should help the company widen its share of the booming weight-loss drug market.

The U.S. Food and Drug Administration said Eli Lilly’s diabetes and weight-loss drugs marketed as Zepbound and Mounjaro are no longer in shortage, signaling that the company has succeeded in ...